Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exagen (XGN) Gross Margin (2018 - 2026)

Exagen filings provide 9 years of Gross Margin readings, the most recent being 58.97% for Q1 2026.

  • On a quarterly basis, Gross Margin rose 10.0% to 58.97% in Q1 2026 year-over-year; TTM through Mar 2026 was 58.32%, a 98.0% decrease, with the full-year FY2025 number at 58.28%, down 123.0% from a year prior.
  • Gross Margin hit 58.97% in Q1 2026 for Exagen, up from 55.35% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 62.08% in Q4 2024 to a low of 20.09% in Q2 2022.
  • Median Gross Margin over the past 5 years was 58.72% (2023), compared with a mean of 54.5%.
  • Biggest five-year swings in Gross Margin: tumbled -3723bps in 2022 and later skyrocketed 3863bps in 2023.
  • Exagen's Gross Margin stood at 50.85% in 2022, then grew by 16bps to 59.17% in 2023, then rose by 5bps to 62.08% in 2024, then dropped by -11bps to 55.35% in 2025, then increased by 7bps to 58.97% in 2026.
  • The last three reported values for Gross Margin were 58.97% (Q1 2026), 55.35% (Q4 2025), and 58.43% (Q3 2025) per Business Quant data.